PMGC Holdings Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
1.070
-0.020 (-1.83%)
At close: Jul 17, 2026, 4:00 PM EDT
1.070
0.00 (0.02%)
After-hours: Jul 17, 2026, 7:58 PM EDT
PMGC Holdings Revenue
PMGC Holdings had revenue of $681.99K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $1.27M. In the year 2025, PMGC Holdings had annual revenue of $590.08K.
Revenue (ttm)
$1.27M
Revenue Growth
n/a
P/S Ratio
3.82
Revenue / Employee
$37,414
Employees
34
Market Cap
4.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 590.08K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 766.28K | 765.45K | 92,557.44% |
| Dec 31, 2021 | 827.00 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HCW Biologics | 6.59M |
| Bio Green Med Solution | 1.53M |
| Silo Pharma | 72.10K |
| Cardio Diagnostics Holdings | 16.57K |
| Alaunos Therapeutics | 3.00K |
| Soligenix | 2.34K |
ELAB News
- 6 days ago - NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications - GlobeNewsWire
- 9 days ago - NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression - GlobeNewsWire
- 13 days ago - PMGC merges AGA Precision Systems into A&B Aerospace - TheFly
- 13 days ago - PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace - GlobeNewsWire
- 18 days ago - Wall Street is Watching These Biotechs - GlobeNewsWire
- 18 days ago - NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences - GlobeNewsWire
- 4 weeks ago - PMGC subsidiary files two new U.S. patent applications on EL-22, EL-32 - TheFly
- 4 weeks ago - NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets - GlobeNewsWire